Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

High mortality caused by Bibersteinia trehalosi septicaemia in adult sheep - A case report.

Szeredi L, Rausch F, Szeleczky Z, Jánosi S.

Acta Vet Hung. 2018 Dec;66(4):509-517. doi: 10.1556/004.2018.045.

PMID:
30580542
2.

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine.

Mier D, Schirmbeck F, Stoessel G, Esslinger C, Rausch F, Englisch S, Eisenacher S, de Haan L, Meyer-Lindenberg A, Kirsch P, Zink M.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 11. doi: 10.1007/s00406-018-0965-4. [Epub ahead of print]

PMID:
30539230
3.

Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms.

Müller H, de Millas W, Gaebel W, Herrlich J, Hasan A, Janssen B, Juckel G, Karow A, Kircher T, Kiszkenow-Bäker S, Klingberg S, Klosterkötter J, Krüger-Özgürdal S, Lambert M, Lautenschlager M, Maier W, Michel TM, Mehl S, Müller BW, Pützfeld V, Rausch F, Riedel M, Sartory G, Schneider F, Wagner M, Wiedemann G, Wittorf A, Wobrock T, Wölwer W, Zink M, Bechdolf A.

Early Interv Psychiatry. 2018 Dec;12(6):1157-1165. doi: 10.1111/eip.12433. Epub 2017 May 19.

PMID:
28524542
4.

Predictors of Competency to Stand Trial in Connecticut's Inpatient Juvenile Competency Restoration Program.

Chien J, Coker KL, Parke S, Tejani N, Sirken RA, Sanchez-Jaquez C, Rausch F, Azeem MW.

J Am Acad Psychiatry Law. 2016 Dec;44(4):451-456.

PMID:
28003389
5.

Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function.

Braun U, Schäfer A, Bassett DS, Rausch F, Schweiger JI, Bilek E, Erk S, Romanczuk-Seiferth N, Grimm O, Geiger LS, Haddad L, Otto K, Mohnke S, Heinz A, Zink M, Walter H, Schwarz E, Meyer-Lindenberg A, Tost H.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12568-12573. Epub 2016 Oct 17.

6.

Aberrant activity and connectivity of the posterior superior temporal sulcus during social cognition in schizophrenia.

Mier D, Eisenacher S, Rausch F, Englisch S, Gerchen MF, Zamoscik V, Meyer-Lindenberg A, Zink M, Kirsch P.

Eur Arch Psychiatry Clin Neurosci. 2017 Oct;267(7):597-610. doi: 10.1007/s00406-016-0737-y. Epub 2016 Oct 21.

PMID:
27770284
7.

Fast sleep spindle reduction in schizophrenia and healthy first-degree relatives: association with impaired cognitive function and potential intermediate phenotype.

Schilling C, Schlipf M, Spietzack S, Rausch F, Eisenacher S, Englisch S, Reinhard I, Haller L, Grimm O, Deuschle M, Tost H, Zink M, Meyer-Lindenberg A, Schredl M.

Eur Arch Psychiatry Clin Neurosci. 2017 Apr;267(3):213-224. doi: 10.1007/s00406-016-0725-2. Epub 2016 Aug 26.

PMID:
27565806
8.

Surfactant proteins of the human larynx.

Sheats M, Schröder H, Rausch F, Bohr C, Kißlinger F, de Tristan J, Iro H, Garreis F, Paulsen F, Schicht M, Bräuer L.

Ann Anat. 2016 Nov;208:135-141. doi: 10.1016/j.aanat.2016.05.010. Epub 2016 Jun 17.

PMID:
27328406
9.

Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.

Eisenacher S, Rausch F, Ainser F, Englisch S, Becker A, Mier D, Fenske S, Meyer-Lindenberg A, Kirsch P, Zink M.

Early Interv Psychiatry. 2018 Aug;12(4):586-595. doi: 10.1111/eip.12350. Epub 2016 May 12.

PMID:
27169782
10.

Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria.

Rausch F, Eisenacher S, Elkin H, Englisch S, Kayser S, Striepens N, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Moritz S, Müller H, Klosterkötter J, Bechdolf A, Zink M, Wagner M.

Psychol Med. 2016 Jul;46(10):2071-81. doi: 10.1017/S0033291716000465. Epub 2016 Apr 20.

PMID:
27094404
11.

Bias against disconfirmatory evidence in the 'at-risk mental state' and during psychosis.

Eisenacher S, Rausch F, Mier D, Fenske S, Veckenstedt R, Englisch S, Becker A, Andreou C, Moritz S, Meyer-Lindenberg A, Kirsch P, Zink M.

Psychiatry Res. 2016 Apr 30;238:242-250. doi: 10.1016/j.psychres.2016.02.028. Epub 2016 Feb 17.

PMID:
27086240
12.

The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state.

Maurer K, Zink M, Rausch F, Häfner H.

Early Interv Psychiatry. 2018 Apr;12(2):217-228. doi: 10.1111/eip.12305. Epub 2016 Jan 23.

PMID:
26801553
13.

Palate Lung Nasal Clone (PLUNC), a Novel Protein of the Tear Film: Three-Dimensional Structure, Immune Activation, and Involvement in Dry Eye Disease (DED).

Schicht M, Rausch F, Beron M, Jacobi C, Garreis F, Hartjen N, Beileke S, Kruse F, Bräuer L, Paulsen F.

Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7312-23. doi: 10.1167/iovs.15-17560. Erratum in: Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3819.

PMID:
26559477
14.

Investigation of metamemory functioning in the at-risk mental state for psychosis.

Eisenacher S, Rausch F, Ainser F, Mier D, Veckenstedt R, Schirmbeck F, Lewien A, Englisch S, Andreou C, Moritz S, Meyer-Lindenberg A, Kirsch P, Zink M.

Psychol Med. 2015 Nov;45(15):3329-40. doi: 10.1017/S0033291715001373. Epub 2015 Jul 23.

PMID:
26201365
15.

Reduced activation in the ventral striatum during probabilistic decision-making in patients in an at-risk mental state.

Rausch F, Mier D, Eifler S, Fenske S, Schirmbeck F, Englisch S, Schilling C, Meyer-Lindenberg A, Kirsch P, Zink M.

J Psychiatry Neurosci. 2015 May;40(3):163-73.

16.

Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents.

Mahal K, Schruefer S, Steinemann G, Rausch F, Schobert R, Biersack B, Höpfner M.

Cancer Chemother Pharmacol. 2015 Apr;75(4):691-700. doi: 10.1007/s00280-015-2685-z. Epub 2015 Jan 25.

PMID:
25618416
17.

Metamemory in schizophrenia: retrospective confidence ratings interact with neurocognitive deficits.

Eifler S, Rausch F, Schirmbeck F, Veckenstedt R, Mier D, Esslinger C, Englisch S, Meyer-Lindenberg A, Kirsch P, Zink M.

Psychiatry Res. 2015 Feb 28;225(3):596-603. doi: 10.1016/j.psychres.2014.11.040. Epub 2014 Dec 2.

PMID:
25530415
18.

The novel surfactant protein SP-H enhances the phagocytosis efficiency of macrophage-like cell lines U937 and MH-S.

Diler E, Schicht M, Rabung A, Tschernig T, Meier C, Rausch F, Garreis F, Bräuer L, Paulsen F.

BMC Res Notes. 2014 Nov 26;7:851. doi: 10.1186/1756-0500-7-851.

19.

Protein modeling and molecular dynamics simulation of the two novel surfactant proteins SP-G and SP-H.

Rausch F, Schicht M, Bräuer L, Paulsen F, Brandt W.

J Mol Model. 2014 Nov;20(11):2513. doi: 10.1007/s00894-014-2513-0. Epub 2014 Nov 9.

PMID:
25381619
20.

Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P, Zink M.

J Psychiatry Neurosci. 2015 Mar;40(2):89-99.

21.

The distribution of human surfactant proteins within the oral cavity and their role during infectious diseases of the gingiva.

Schicht M, Stengl C, Sel S, Heinemann F, Götz W, Petschelt A, Pelka M, Scholz M, Rausch F, Paulsen F, Bräuer L.

Ann Anat. 2015 May;199:92-7. doi: 10.1016/j.aanat.2014.05.040. Epub 2014 Jun 23.

PMID:
25023567
22.

Neurocognitive capabilities modulate the integration of evidence in schizophrenia.

Eifler S, Rausch F, Schirmbeck F, Veckenstedt R, Englisch S, Meyer-Lindenberg A, Kirsch P, Zink M.

Psychiatry Res. 2014 Sep 30;219(1):72-8. doi: 10.1016/j.psychres.2014.04.056. Epub 2014 May 14.

PMID:
24880580
23.

Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia.

Rausch F, Mier D, Eifler S, Esslinger C, Schilling C, Schirmbeck F, Englisch S, Meyer-Lindenberg A, Kirsch P, Zink M.

Schizophr Res. 2014 Jul;156(2-3):143-9. doi: 10.1016/j.schres.2014.04.020. Epub 2014 May 13.

PMID:
24831391
24.

SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation.

Schicht M, Rausch F, Finotto S, Mathews M, Mattil A, Schubert M, Koch B, Traxdorf M, Bohr C, Worlitzsch D, Brandt W, Garreis F, Sel S, Paulsen F, Bräuer L.

Eur Respir J. 2014 Aug;44(2):447-56. doi: 10.1183/09031936.00179813. Epub 2014 Apr 17.

25.

Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function.

Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Müller H, Klosterkötter J, Bechdolf A.

Acta Psychiatr Scand. 2014 Sep;130(3):214-26. doi: 10.1111/acps.12258. Epub 2014 Feb 26.

PMID:
24571191
26.

The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity.

Rausch F, Eifler S, Esser A, Esslinger C, Schirmbeck F, Meyer-Lindenberg A, Zink M.

Compr Psychiatry. 2013 Oct;54(7):1068-76. doi: 10.1016/j.comppsych.2013.04.016. Epub 2013 Jun 4.

PMID:
23759152
27.

Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study.

Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M.

Schizophr Bull. 2013 Nov;39(6):1261-71. doi: 10.1093/schbul/sbs123. Epub 2012 Oct 27.

28.

Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study.

Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M.

J Psychopharmacol. 2013 Apr;27(4):349-57. doi: 10.1177/0269881112463470. Epub 2012 Oct 24.

PMID:
23095245
29.

"SP-G", a putative new surfactant protein--tissue localization and 3D structure.

Rausch F, Schicht M, Paulsen F, Ngueya I, Bräuer L, Brandt W.

PLoS One. 2012;7(10):e47789. doi: 10.1371/journal.pone.0047789. Epub 2012 Oct 18.

30.

[Psychopathology and hypodense basal ganglion lesions: early manifestation of cognitive-mnestic deficits in an 18-year-old male patient with familial neurodegeneration and iron accumulation in the brain].

Eßer A, Rausch F, Eifler S, Zink M.

Nervenarzt. 2013 Jul;84(7):851-3. doi: 10.1007/s00115-012-3617-3. German. No abstract available.

PMID:
22911319
31.

Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.

Esslinger C, Englisch S, Inta D, Rausch F, Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A, Zink M.

Schizophr Res. 2012 Sep;140(1-3):114-21. doi: 10.1016/j.schres.2012.06.025. Epub 2012 Jul 10.

PMID:
22784688
32.

Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents.

Schirmbeck F, Nieratschker V, Frank J, Englisch S, Rausch F, Meyer-Lindenberg A, Rietschel M, Zink M.

Psychiatr Genet. 2012 Oct;22(5):245-52. doi: 10.1097/YPG.0b013e328353fbee.

PMID:
22531293
33.

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.

Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M.

Psychol Med. 2011 Nov;41(11):2361-73. doi: 10.1017/S0033291711000419. Epub 2011 Apr 5.

PMID:
21466748
34.

Molecular and structural basis of metabolic diversity mediated by prenyldiphosphate converting enzymes.

Brandt W, Bräuer L, Günnewich N, Kufka J, Rausch F, Schulze D, Schulze E, Weber R, Zakharova S, Wessjohann L.

Phytochemistry. 2009 Oct-Nov;70(15-16):1758-75. doi: 10.1016/j.phytochem.2009.09.001. Epub 2009 Oct 29. Review.

PMID:
19878958
35.

Incidence and treatment of budding yeasts in canine otitis externa.

Rausch FD, Skinner GW.

Mod Vet Pract. 1978 Dec;59(12):914-5.

PMID:
732804
36.

[Risks in modern diagnosis].

Rausch F.

J R Coll Physicians Lond. 1978 Apr;12(3):272-85. German.

37.

[Check-up programs for the geriatric practice?].

Rausch F.

Lebensversicher Med. 1973 Sep;25(5):109-13. German. No abstract available.

PMID:
4149075
38.

[Short-term fibrinolytic treatment in acute myocardial infarction].

Breddin K, Ehrly AM, Fechler L, Frick D, König H, Kraft H, Krause H, Krzywanek HJ, Kutschera J, Lösch HW, Ludwig O, Mikat B, Rausch F, Rosenthal P, Sartory S, Voigt G, Wylicil P.

Dtsch Med Wochenschr. 1973 Apr 27;98(17):861-73. German. No abstract available.

PMID:
4571884
39.

Circadian variation in plasma cortisol and corticosterone in pigs and mares.

Bottoms GD, Roesel OF, Rausch FD, Akins EL.

Am J Vet Res. 1972 Apr;33(4):785-90. No abstract available.

PMID:
5017871
40.

[The effect of an amino acid mixture on the gastric and pancreatic secretion].

Heider H, Rausch F.

Arzneimittelforschung. 1968 Jul;18(7):877-80. German. No abstract available.

PMID:
4885100
41.

[Diets for diagnosis].

Rausch F.

Med Welt. 1966 Apr 23;17:915-25. German. No abstract available.

PMID:
5985769
42.

[Control of the angina pectoris pain by intensain].

Gille H, Rausch F.

Med Welt. 1966 Apr 2;14:715-9. German. No abstract available.

PMID:
5957301
43.

[Therapeutic problems and therapeutic guidelines in focal diseases].

Rausch F.

Therapiewoche. 1965 Dec;15(23):1230-7. German. No abstract available.

PMID:
5885815
44.

[ICTERUS SPECTRUM. A BIOCHEMICAL SYNOPSIS OF JAUNDICE FOR USE IN GENERAL PRACTICE].

RAUSCH F, BRAUMANN F.

Dtsch Med J. 1963 Sep 5;14:532-9. German. No abstract available.

PMID:
14087484
45.

[Thoughts on nutrition in gastrointestinal diseases].

RAUSCH F.

Dtsch Med J. 1961 Mar 5;12:152-6. German. No abstract available.

PMID:
13739812
46.

[Serogenetic encephalomyelitis after tetanus vaccination].

LEDERBOGEN K, DROSTE R, RAUSCH F.

Dtsch Med J. 1960 Jul 20;11:362-5. German. No abstract available.

PMID:
14415127
47.

[Catamneses of patients cured from focal infection].

RAUSCH F, FLEISCHMANN K.

Medizinische. 1959 Nov 7;No 45:2159-61. German. No abstract available.

PMID:
14436496
48.

[Iproniazid (marsilid) in the angina pectoris syndrome therapeutically hard to control].

LEDERBOGEN K, RAUSCH F.

Munch Med Wochenschr. 1959 Sep 4;101:1490-2. German. No abstract available.

PMID:
14415128
49.

[Therapy of fatty liver and fatty cirrhosis by thloctic acid; comparative examinations by liver biopsy].

RAUSCH F.

Arztl Forsch. 1958 Feb 10;12(2):I/79-86. German. No abstract available.

PMID:
13508413
50.

[Chronic non-specific gastro-enteritis syndrome].

RAUSCH F, HARWERTH H.

Arztl Forsch. 1957 Apr 10;11(4):I/204-12. German. No abstract available.

PMID:
13410689

Supplemental Content

Loading ...
Support Center